Patents Assigned to METABALON, INC.
  • Biomarkers for Prostate Cancer and Methods Using the Same
    Publication number: 20100292331
    Abstract: Methods for identifying and evaluating suites of biochemical and/or gene entities useful as biomarkers for early prediction of prostate cancer, disease grading, target identification/validation, and monitoring of drug efficacy are provided. Also provided are suites of small molecule entities as biomarkers for prostate cancer.
    Type: Application
    Filed: September 18, 2007
    Publication date: November 18, 2010
    Applicant: METABALON, INC.
    Inventors: Matthew W. Mitchell, Alvin Berger, Kay A. Lawton